Show simple item record

dc.contributor.authorOtieno, Micheal F
dc.contributor.authorOuma, C
dc.contributor.authorDavenport, GC
dc.contributor.authorAwandare, GA
dc.contributor.authorKeller, CC
dc.contributor.authorWere, T
dc.contributor.authorVulule, JM
dc.contributor.authorMartinson, J
dc.contributor.authorOng'echa, JM
dc.contributor.authorFerrell, RE
dc.contributor.authorPerkins, DJ
dc.date.accessioned2018-01-24T13:27:44Z
dc.date.available2018-01-24T13:27:44Z
dc.date.issued2012
dc.identifier.urihttps://repository.maseno.ac.ke/handle/123456789/250
dc.description.abstractInterleukin (IL)-1beta is a cytokine released as part of the innate immune response to Plasmodium falciparum. Because the role played by IL-1beta polymorphic variability in conditioning the immunopathogenesis of severe malarial anemia (SMA) remains undefined, relationships between IL-1beta promoter variants (-31C/T and-511A/G), SMA (hemoglobin [Hb] level< 6.0 g/dL), and circulating IL-1beta levels were investigated in children with parasitemia (n= 566) from western Kenya. The IL-1beta promoter haplotype-31C/-511A (CA) was associated with increased risk of SMA (Hb level< 6.0 g/dL; odds ratio [OR], 1.98 [95% confidence interval {CI}, 1.55-2.27]; P<. 05) and reduced circulating IL-1beta levels (p<. 05). The TA (-31T/-511A) haplotype was nonsignificantly associated with protection against SMA (OR, 0.52 [95% CI, 0.18-1.16]; p=. 11) and elevated IL-1beta production (p<. 05) …en_US
dc.publisherPubMeden_US
dc.titlePolymorphic Variability in the Interleukin (IL)-1Beta Promoter Conditions Susceptibility to Severe Malarial Anemia and Functional Changes in IL-1Beta Productionen_US
dc.typeArticleen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record